These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20829618)

  • 1. Cardiovascular disease in Cushing's syndrome: heart versus vasculature.
    De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
    Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in Cushing's syndrome.
    Chanson P; Salenave S
    Neuroendocrinology; 2010; 92 Suppl 1():96-101. PubMed ID: 20829627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk in Cushing's syndrome.
    Arnaldi G; Mancini T; Polenta B; Boscaro M
    Pituitary; 2004; 7(4):253-6. PubMed ID: 16416038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome and cardiovascular risk in Cushing's syndrome.
    Pivonello R; Faggiano A; Lombardi G; Colao A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):327-39, viii. PubMed ID: 15850845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we evaluate for cardiovascular disease in patients with Cushing's syndrome?
    Fallo F; Sonino N
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):768-71. PubMed ID: 19508589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess.
    Pivonello R; De Martino MC; Iacuaniello D; Simeoli C; Muscogiuri G; Carlomagno F; De Leo M; Cozzolino A; Colao A
    Front Horm Res; 2016; 46():54-65. PubMed ID: 27212264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure.
    Pecori Giraldi F; Toja PM; De Martin M; Maronati A; Scacchi M; Omboni S; Cavagnini F; Parati G
    Horm Metab Res; 2007 Dec; 39(12):908-14. PubMed ID: 18046661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid action and the clinical features of Cushing's syndrome.
    Yanovski JA; Cutler GB
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):487-509. PubMed ID: 7805650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure.
    Toja PM; Branzi G; Ciambellotti F; Radaelli P; De Martin M; Lonati LM; Scacchi M; Parati G; Cavagnini F; Pecori Giraldi F
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):332-8. PubMed ID: 21854405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines and cardiovascular risk in Cushing's syndrome.
    Valassi E; Biller BM; Klibanski A; Misra M
    Neuroendocrinology; 2012; 95(3):187-206. PubMed ID: 22057123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of dyslipidemia in Cushing's syndrome.
    Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
    Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dyslipidemia in Cushing's syndrome.
    Greenman Y
    Neuroendocrinology; 2010; 92 Suppl 1():91-5. PubMed ID: 20829626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
    Müller A; Mulhall JP
    Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.